Sandy W. Wong, MD

Dr. Sandy Wong is an Assistant Clinical Professor in the Division of Hematology/Oncology at University of California San Francisco (UCSF) and director at  Amyloidosis Program at UCSF. She cares for people with MGUS (monoclonal gammopathy of undetermined significance), smoldering myeloma, multiple myeloma and amyloidosis.

Dr. Wong has a special interest in amyloidosis patients, and her research focuses on this disease. She studies patients with AL amyloidosis (the most common type) whose kidneys are affected, as well as those with chromosomal abnormalities. She is also designing a clinical trial for a promising new drug to treat multiple myeloma.

After graduating from Brown University with a degree in human biology, Wong earned her medical degree at the University of Massachusetts. She then completed an internal medicine residency followed by a hematology-oncology fellowship at Tufts Medical Center. Wong is a member of the American Society of Hematology and American Society of Clinical Oncology.

Representative Publications:

Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p
Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment
Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma